I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Crohn's Disease: Symptoms, Treatment & Living with IBD
At a glance
FrequencyOne of the most common inflammatory bowel diseases (IBD); hundreds of thousands of people in Germany alone are estimated to be affected by IBD
OnsetOften first appears between ages 15 and 35; a second peak can occur in older age
CurableCurrently not curable — but generally well manageable; the goal is the longest possible remission
Affected areaCan affect the entire digestive tract, most commonly the lower end of the small bowel (terminal ileum) and the colon
MedicationsCorticosteroids (flare), immunosuppressants (azathioprine, MTX), biologics (adalimumab, infliximab, ustekinumab, risankizumab and others), JAK inhibitor (upadacitinib)
Crohn's disease is a chronic inflammatory bowel disease (IBD). Unlike ulcerative colitis, which generally affects only the colon, Crohn's disease can affect the entire digestive tract — from mouth to anus. The lower end of the small bowel (terminal ileum) and the colon are most commonly affected.¹
Typical for Crohn's disease is that inflammation can affect all layers of the bowel wall (so-called transmural inflammation) and typically runs in flares: phases of active disease alternate with symptom-free or symptom-poor phases (remission). Healthy bowel segments can lie between inflamed segments (so-called segmental involvement, or "skip lesions").¹
Crohn's disease vs. ulcerative colitis
Crohn's disease
Whole digestive tract possible
All wall layers (transmural)
Segmental involvement (skip lesions)
Fistulas and strictures common
Surgery not curative
Ulcerative colitis
Colon only
Mucosa only
Continuous involvement
Visible blood in stool typical
Colectomy potentially curative
Common features
Chronic, relapsing courses
Misdirected immune response
Treatment partly overlaps
Extra-intestinal symptoms
Lifelong management
Not curable — but well manageable
With modern, individually tailored therapy, most affected people can achieve a good quality of life long term. Treatment options have expanded substantially in recent years.¹,³
2. Symptoms
Symptoms depend on which part of the bowel is affected, how severe the inflammation is and whether complications are present. Many symptoms are non-specific and are often initially misinterpreted as irritable bowel syndrome or stress reactions.¹
Common bowel symptoms
Chronic diarrhoea — often for weeks, sometimes also at night; in contrast to ulcerative colitis, generally without visible blood
Abdominal pain — often in the right lower abdomen (with ileal involvement), can be cramping
Nausea, loss of appetite, weight loss
Bloating and feeling of fullness
Fever — particularly during acute flares
Bowel complications
Fistulas — abnormal connecting passages between bowel and skin, other organs or the perianal area; affects a relevant proportion of people during the disease course
Strictures (narrowings) — through scar formation after repeated inflammation; can lead to bowel obstruction
Abscesses — collections of pus, often in the perianal area
Symptoms outside the bowel (extra-intestinal)
Joint pain — most common extra-intestinal manifestation
Iron deficiency and anaemia — through chronic inflammation and/or malabsorption
Increased risk of osteoporosis — particularly with long-term corticosteroid therapy
3. Causes and risk factors
The exact cause of Crohn's disease is currently not fully understood. An interplay of several factors is thought to be involved.¹
Genetics: familial clustering exists. First-degree relatives have a substantially increased risk. Several genes (e.g. NOD2/CARD15) have been identified — but Crohn's disease is not a classic hereditary disease.
Immune system: reacts abnormally to the body's own gut flora and components of the bowel wall. The result is a chronic inflammatory response that does not resolve on its own.
Gut microbiome: the composition of the gut flora is often altered in people with Crohn's disease (dysbiosis). Whether this is cause or consequence is still being researched.
Smoking: the most important modifiable risk factor. It increases the risk of Crohn's disease, worsens the course, increases flare frequency and the risk of surgery. Stopping smoking is one of the most effective measures.¹
Other factors: early antibiotic treatment in childhood, dietary factors (e.g. heavily processed foods) and stress are discussed as possible contributors — the evidence here is not yet conclusive.
4. Diagnosis
A single examination is typically not sufficient for the diagnosis. Typically, a combination of history, laboratory tests, imaging and endoscopy is used.¹
Ileocolonoscopy with biopsies: the most important examination. The colon and the lower end of the small bowel are assessed endoscopically and tissue samples are taken. Typical findings: segmental inflammation, cobblestone appearance, longitudinal ulcerations, granulomas on histology.
Laboratory: CRP and ESR are typically elevated during active inflammation. Faecal calprotectin is a sensitive marker of inflammatory activity in the bowel and is also useful for follow-up. Full blood count (anaemia?), iron, ferritin, vitamin B12, folic acid and vitamin D are typically also measured.¹
Small bowel MRI (MR enterography): imaging of choice for the small bowel, which cannot be fully assessed endoscopically. Shows wall thickening, strictures, fistulas and abscesses. Uses no radiation.
Abdominal ultrasound: can show wall thickening, strictures and abscesses non-invasively. Often used as the first imaging modality and for follow-up.
Additional: stool testing for infections (especially Clostridioides difficile) to rule out an infectious cause. Capsule endoscopy when small bowel involvement is suspected but not seen on MR enterography.
5. Treatment: medications and strategies
Treatment depends on disease activity, affected area, previous course and individual factors. Current guidelines recommend early, effective therapy with the goal of steroid-free remission and, where possible, mucosal healing (endoscopic remission). The decision is typically made by the treating gastroenterology team.¹,³
FlareCorticosteroid flare therapy
Budesonide
A locally acting corticosteroid, often used as first choice for mild to moderately active Crohn's disease with ileal involvement. Fewer systemic side effects than conventional corticosteroids.
Systemic corticosteroids (e.g. prednisolone)
For more severe flares or failure of budesonide. Acts quickly, but should typically be used for as short a time as possible — corticosteroids are not a long-term medication for IBD.
MaintenanceImmunosuppressants
Azathioprine / 6-mercaptopurine
Often used for maintenance of remission. Onset of effect typically takes several months. Regular laboratory monitoring (full blood count, liver values) is needed.
Methotrexate (MTX)
An alternative, particularly with azathioprine intolerance.
BiologicsAnti-TNF, anti-IL, anti-integrin
Anti-TNF: infliximab, adalimumab
The longest-established biologics in Crohn's disease. Inhibit the inflammatory mediator TNF-alpha. Typically used for moderate to severe disease or after failure of immunosuppressants. Also effective for fistulas. Biosimilars are available and are typically considered equivalent.¹,³
Anti-IL-12/23: ustekinumab
Inhibits interleukins 12 and 23. Often used when anti-TNF does not work sufficiently or is not tolerated.
Anti-IL-23: risankizumab
A newer biologic that selectively inhibits IL-23. Added to current guidelines and shows good efficacy in studies for Crohn's disease.³
Integrin inhibitor: vedolizumab
Acts gut-selectively by inhibiting the migration of inflammatory cells into the bowel wall. Advantage: less systemic immunosuppression.
New 2023/24JAK inhibitor (oral)
Upadacitinib
An orally taken medication (tablet instead of injection/infusion). Approved for Crohn's disease in 2023 and added to current guidelines. Inhibits the Janus kinases (JAK), which are involved in inflammatory signal transmission.³
Corticosteroids are not a long-term medicationSteroid-free remission is the treatment goal. If corticosteroids are needed repeatedly or for longer than a few months, treatment escalation (e.g. to biologics) is typically discussed.
6. Surgery
A relevant proportion of affected people need at least one operation during the course of the disease — often because of strictures, fistulas or abscesses that cannot be sufficiently controlled with medication. Surgery is typically performed as sparingly as possible (bowel-sparing resection), to preserve as much healthy bowel as possible.¹
After surgery, recurrences at the anastomotic site are common. Medication-based recurrence prophylaxis after surgery is therefore typically recommended. Stopping smoking substantially reduces the risk of recurrence after surgery.
7. Nutrition
There is no single dietary approach that can cure or reliably control Crohn's disease. Nevertheless, nutrition plays a relevant role.¹
During an acute flare: easily digestible food; for severe flares, temporary enteral nutrition (drink supplements) can be useful — in children, exclusive enteral nutrition is even an equivalent alternative to corticosteroids
In remission: a balanced and minimally processed diet is generally recommended; a strict diet is typically not necessary
Identify individual intolerances: many people do not tolerate certain foods — a food diary can help
Replacing deficiencies: iron, vitamin B12, folic acid, vitamin D, zinc and calcium should be regularly checked and supplemented as needed — particularly with small bowel involvement or after bowel resections
8. Mental health and quality of life
Crohn's disease is more than a bowel disease. The mental health burden is often substantial — even during remission.¹
Anxiety about the next flare
Fatigue (chronic exhaustion) — even with normal inflammation values; can affect quality of life more than the bowel symptoms themselves
Shame — diarrhoea, urgency, fistulas and stoma can restrict social life
Increased risk of depression and anxiety disorders
Psychological support (e.g. behavioural therapy, stress management) can substantially improve quality of life and is part of guideline-based care. Crohn's & Colitis UK and Crohn's & Colitis Foundation (US) offer information and peer support.
9. Daily life with Crohn's disease
Medications: regular and timely intake is crucial — even in remission. Immunosuppressants and biologics protect against the next flare. Stopping on your own increases the risk of a flare.
Smoking: stopping smoking is the most important single measure people can take themselves. Smoking worsens the course, increases flare frequency and the risk of surgery.
Surveillance: regular colonoscopy follow-ups are recommended for long-standing Crohn's disease with colonic involvement — colorectal cancer risk is slightly increased long term. Monitor bone density (osteoporosis risk with corticosteroids). Check vaccination status — special vaccination recommendations apply with immunosuppression.
Work and travel: most people with well-adjusted treatment can hold normal jobs. When travelling: take sufficient medication, observe cooling requirements for biologics.
Disability and rehabilitation: for severe courses, disability status (varies by country) can be applied for. Rehabilitation programmes are an established part of IBD care and can help with daily life.
How brite helps you with Crohn's disease
Tapering corticosteroids, azathioprine daily, a biologic every few weeks — and in between, calprotectin checks, vitamin levels and a nutrition plan. IBD treatment is set up over years and needs reliable routine. That's exactly what brite is built for.
Intake reminder — immunosuppressants daily, biologic appointments every few weeks, corticosteroid tapering schedules with stepwise dose changes: brite reminds you on time. Particularly during corticosteroid tapering, the right dose on the right day matters.
Drug interaction check — azathioprine plus allopurinol (can raise levels dangerously)? MTX plus ibuprofen or trimethoprim? A biologic plus a live vaccine? brite shows the critical combinations in IBD treatment.
Health journal — track flare activity, calprotectin, CRP, stool frequency, weight and accompanying symptoms (fatigue, joints) over time. At the next gastroenterology appointment, show what really happened.
Digital medication plan — all IBD medications clearly organised for gastroenterology, GP and emergency care. In an emergency, treating clinicians see immediately which immunosuppressants and biologics are being taken — important e.g. with acute infections.
Both are inflammatory bowel diseases (IBD). Crohn's disease can affect the entire digestive tract and involves all layers of the bowel wall; ulcerative colitis is generally limited to the colon and the mucosal layer. Treatment overlaps in part but differs in important details — for example, surgical cure is only possible in ulcerative colitis (colectomy).¹
Currently it cannot. The goal of treatment is the longest possible remission — a phase with no or minimal symptoms and ideally with healing of the bowel mucosa. Many people with modern therapy achieve a good quality of life.¹,³
No — corticosteroids in Crohn's disease are typically a flare medication, not a long-term medication. If they are needed repeatedly or for longer than a few months, treatment escalation (e.g. to biologics or immunosuppressants) is typically discussed. Steroid-free remission is the treatment goal.¹
Biologics are biotechnologically produced medications that selectively block specific inflammatory mediators. For Crohn's disease, infliximab, adalimumab (anti-TNF), ustekinumab (anti-IL-12/23), risankizumab (anti-IL-23) and vedolizumab (integrin inhibitor), among others, are licensed. They are typically given as infusion or injection.¹,³
A JAK inhibitor taken as a tablet — not a biologic in the strict sense but a so-called small molecule. It was approved for Crohn's disease in 2023 and added to current guidelines. It inhibits the Janus kinases involved in inflammatory signalling.³
There is no single Crohn's disease diet. During a flare, easily digestible food is typically recommended; in remission, a balanced and minimally processed diet. Individual intolerances should be identified (food diary). Deficiencies (iron, B12, vitamin D) should be regularly checked and supplemented as needed.¹
Stress does not cause Crohn's disease — but it can promote flares and amplify symptom perception. Stress management (e.g. behavioural therapy, relaxation techniques, regular exercise) is recommended as a complement to medical therapy.
Yes — with well-adjusted treatment most people can hold normal jobs. With severe disease courses or frequent flares, disability status (varies by country) can be applied for, providing employment protections and adjustments.
Medical disclaimer: This article is for general information only and does not replace medical advice, diagnosis or treatment. IBD medications should typically not be stopped or changed in dose on your own. With signs of a severe flare (severe abdominal pain, high fever, bloody diarrhoea, signs of bowel obstruction), seek medical care immediately. Medication choice and dosing are always determined individually by the treating gastroenterology team. Last updated: April 2026.